core revenu growth bit light expect though like least line
adjust data center outag importantli underli revenu growth trend
remain consist new growth target fy revenue/ep guidanc
rais reiter outperform rate valuat remain favor like
 capac tool group
earn call wednesday juli et dial-in
revenu consensu estim essenti
line forecast revenu growth could low
high light expect accord manag data
center outag final week quarter shift order
neg impact overal compani organ revenu growth primarili
ai segment caveat yet know exact growth rate due round
adjust data center outag core revenu growth would
expect expect beat
life scienc solut lss revenu beat consensu estim
forecast organ revenu growth impress
forecast believ continu robust biopharma demand
particularli bioproduct tool drove strong organ revenu growth
analyt instrument ai revenu light expect
organ revenu growth light forecast accord
manag data center outag shift order neg
impact overal compani organ revenu growth primarili ai segment
impli data center outag impact ai revenu account
round
specialti diagnost sdx revenu consensu
estim forecast believ key differ
consensu estim actual result anatom patholog divestitur close
later expect suspect sell-sid model adequ updat
dynam revenu growth forecast
lab product servic lp revenu consensu
estim forecast revenu growth forecast
worth note y/i stack comparison much unfavor
rel
gross margin y/i expect bit surpris
gross margin perform given ai revenu primarili instrument typic
carri lower gross margin consum light expect said
acknowledg volum lower typic due data center outag
oper margin y/i line expect despit
weaker expect gross margin unexpect data center outag
pleas see page report import disclosur
neg impact revenu growth convers line manag
ep consensu estim forecast ep would
line consensu estim adjust lower expect tax
rate non-oper expens
increas full year revenu guidanc prior
repres increas midpoint best guess
increas due later expect close anatom patholog
divestitur fx model indic anyth fx got bit wors rel prior
guidanc assumpt assum fx guidanc chang conserv
estim compani rais core revenu guidanc ep
guidanc rais prior manag attribut
guidanc increas primarili reflect stronger oper perform
put take hold serv
recogn coupl variabl quarter servic outag delay ai
divestitur believ may beat consensu expect core revenu
growth importantli fy revenu growth outlook increas
believ organ basi fy ep outlook slightli increas base
initi disclosur appear littl chang would alter thesi compani
remain well posit gener core revenu growth expand margin
potenti meaning capit deploy share trade discount
peer price-to-earnings basi believ continu well posit rel
compani report thomson eikon cowen compani
cowen vs consensu mm except organ organ fx reiter gross includ tariff ap brammer fx select revenu metric mm except scienc product statement mm except currenc forecast pre-tax per count rate light forecast ep consensu estim forecast ep would line consensu estim adjust lower expect tax rate non-oper expens streetaccount consensu lss revenu beat consensu estim forecast organ revenu growth impress forecast believ continu robust biopharma demand particularli bioproduct tool drove strong organ revenu growth streetaccount consensu ai revenu light expect organ revenu growth light forecast accord manag data center outag shift order neg impact overal compani organ revenu growth primarili ai segment impli data center outag impact ai revenu account round repres headwind organ revenu growth streetaccount consensu sdx revenu consensu estim forecast believ key differ consensu estim actual result anatom patholog divestitur close later expect suspect sell-sid model adequ updat dynam revenu growth forecast streetaccount consensu lp revenu consensu estim forecast revenu growth forecast worth note y/i stack comparison much unfavor rel consensu organ revenu consensu estim essenti line forecast revenu growth could low high light expect accord manag data center outag final week quarter shift order neg impact overal compani organ revenu growth primarili ai segment caveat yet know exact growth rate due round adjust data center outag core revenu growth would expect expect beat gross margin y/i expect bit surpris gross margin perform given ai revenu primarili instrument typic carri lower gross margin consum light expect said acknowledg volum lower typic due data center outag expens percentag total revenu line forecast sg expens forecast oper margin y/i line expect despit weaker expect gross margin unexpect data center outag neg impact revenu cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk includ limit macroeconom deterior current
level inabl execut integr eros market share price due
competit inabl deliv incremental/decrement margin target value-
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc juli et dissemin juli et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
